Arrowstreet International Equity - Alpha Extension Fund |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Arrowstreet International Equity - Alpha Extension Fund |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Arrowstreet International Equity - Alpha Extension Fund |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Arrowstreet International Equity - Alpha Extension Fund |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Arrowstreet International Equity ACWI ex US Alpha Extension Trust Fund |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Barclays Capital Securities Ltd |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Barclays Capital Securities Ltd |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Barclays Capital Securities Ltd |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Barclays Capital Securities Ltd |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Barclays Capital Securities Ltd |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Barclays Capital Securities Ltd |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Citigroup Global Markets Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Europe) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Japan) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Japan) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Japan) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Japan) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Japan) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Japan) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Japan) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Japan) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Japan) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Japan) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Japan) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Japan) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Credit Suisse Securities (Japan) Limited |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Deutsche Bank Aktiengesellschaft, London ドイツ銀行ロンドン支店 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
GOLDMAN SACHS INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JANE STREET GLOBAL TRADING, LLC |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JANE STREET GLOBAL TRADING, LLC |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JANE STREET GLOBAL TRADING, LLC |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JANE STREET GLOBAL TRADING, LLC |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JANE STREET GLOBAL TRADING, LLC |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JANE STREET GLOBAL TRADING, LLC |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JANE STREET GLOBAL TRADING, LLC |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JANE STREET GLOBAL TRADING, LLC |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JANE STREET GLOBAL TRADING, LLC |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JANE STREET GLOBAL TRADING, LLC |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JANE STREET GLOBAL TRADING, LLC |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JANE STREET GLOBAL TRADING, LLC |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JANE STREET GLOBAL TRADING, LLC |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JANE STREET GLOBAL TRADING, LLC |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JANE STREET GLOBAL TRADING, LLC |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JANE STREET GLOBAL TRADING, LLC |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JANE STREET GLOBAL TRADING, LLC |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JANE STREET GLOBAL TRADING, LLC |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JANE STREET GLOBAL TRADING, LLC |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JANE STREET GLOBAL TRADING, LLC |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JANE STREET GLOBAL TRADING, LLC |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JANE STREET GLOBAL TRADING, LLC |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JANE STREET GLOBAL TRADING, LLC |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JANE STREET GLOBAL TRADING, LLC |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JANE STREET GLOBAL TRADING, LLC |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JANE STREET GLOBAL TRADING, LLC |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JANE STREET GLOBAL TRADING, LLC |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JANE STREET GLOBAL TRADING, LLC |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JANE STREET GLOBAL TRADING, LLC |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JANE STREET GLOBAL TRADING, LLC |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JANE STREET GLOBAL TRADING, LLC |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JANE STREET GLOBAL TRADING, LLC |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPモルガン証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPモルガン証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPモルガン証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPモルガン証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPモルガン証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPモルガン証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPモルガン証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPモルガン証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPモルガン証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPモルガン証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPモルガン証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPモルガン証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPモルガン証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPモルガン証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPモルガン証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPモルガン証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPモルガン証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPモルガン証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPモルガン証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPモルガン証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPモルガン証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPモルガン証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPモルガン証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPモルガン証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPモルガン証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPモルガン証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPモルガン証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPモルガン証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPモルガン証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
JPモルガン証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MERRILL LYNCH INTERNATIONAL |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
MWIS Eureka Fund |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Nomura International plc |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
OXAM QUANT FUND LIMITED |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Segregated Portfolio D |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Segregated Portfolio D |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Segregated Portfolio D |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Segregated Portfolio D |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Segregated Portfolio D |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
Segregated Portfolio D |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
UBS AG |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
Oncolys BioPharma Inc. |
Subscription Required |
Subscription Required |
Japan |